Status:

COMPLETED

A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19

Lead Sponsor:

Limbix Health, Inc.

Conditions:

Depression

Eligibility:

All Genders

13-21 years

Phase:

NA

Brief Summary

Over 3 million teenagers in the USA have depression, and rates of depression and suicide are sharply increasing. Teenage depression has far-reaching consequences including impairments in academic and ...

Detailed Description

Depression in adolescence is a public health crisis, with incidence and suicide rates rising sharply over the past decade. The COVID-19 global pandemic, along with mandated social and physical distanc...

Eligibility Criteria

Inclusion

  • Between the ages of 13 and 21
  • Self-reported symptoms of depression
  • Will be residing in the USA for the duration of the 5-week study
  • Under the care of a US-based primary care and/or licensed mental healthcare provider and willing and able to provide the name and contact information of the provider during consent appointment.
  • English fluency and literacy of adolescent and consenting legal guardian if under 18
  • Access to a smartphone (iPhone 5s or later or running Android 4.4 KitKat or later) and regular internet access
  • Willing to provide informed e-consent/assent and have legal guardian willing to provide informed e-consent if under 18.

Exclusion

  • Self-reported lifetime suicide attempt or active self-harm or active suicidal ideation with intent
  • Have a diagnosis by a clinician of bipolar disorder, substance use disorder, or any psychotic disorder including schizophrenia
  • Incapable of understanding or completing study procedures and digital intervention as determined by participant, patient/legal guardian, healthcare provider, or clinical research team

Key Trial Info

Start Date :

July 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 16 2022

Estimated Enrollment :

227 Patients enrolled

Trial Details

Trial ID

NCT04524598

Start Date

July 20 2020

End Date

January 16 2022

Last Update

May 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Limbix Health, Inc.

San Francisco, California, United States, 94104